In this study, primary breast tumor tissues were found to have higher expression levels of RUNX2 and miR-10a/b than adjacent non-tumor tissue, and overexpression in any of these three genes was significantly associated with poor clinical outcome. Here, RUNX2 is linked to neoplasm.